These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1789066)

  • 1. A null cell adenoma of the pituitary detected seven years after removal of a prolactinoma. Recurrence or de novo tumourigenesis?
    Watanobe H; Kudo K; Okushima T; Fukita Y; Takebe K
    Acta Endocrinol (Copenh); 1991 Dec; 125(6):700-4. PubMed ID: 1789066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
    Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary enlargement with suprasellar extension in functional hyperprolactinemia due to lactotroph hyperplasia: a pseudotumoral disease.
    Peillon F; Dupuy M; Li JY; Kujas M; Vincens M; Mowszowicz I; Derome P
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1008-15. PubMed ID: 1939514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexisting corticotroph and lactotroph adenomas: case report with reference to the relationship of corticotropin and prolactin excess.
    Wynne AG; Scheithauer BW; Young WF; Kovacs K; Ebersold MJ; Horvath E
    Neurosurgery; 1992 Jun; 30(6):919-23. PubMed ID: 1319562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
    Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up.
    Feigenbaum SL; Downey DE; Wilson CB; Jaffe RB
    J Clin Endocrinol Metab; 1996 May; 81(5):1711-9. PubMed ID: 8626821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple intracranial recurrent tumors with hyperprolactinemia combined with a parasellar malignant fibrous histiocytoma long after transfrontal surgery and irradiation to a pituitary adenoma.
    Fujikawa M; Okamura K; Sato K; Shiratsuchi M; Yao T; Mizokami T; Fujishima M
    J Endocrinol Invest; 2001 Jun; 24(6):448-53. PubMed ID: 11434670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
    Ma W; Ikeda H; Yoshimoto T
    Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-functioning pituitary adenoma initially mimicking a microprolactinoma: The case for long-term follow-up of patients with mild hyperprolactinemia?
    Losa M; Mortini P; Giovanelli M
    J Endocrinol Invest; 2005 Apr; 28(4):367-70. PubMed ID: 15966512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report of sarcoma of the sella caused by postoperative radiotherapy for a prolactin-producing pituitary adenoma.
    Kurosaki M; Kambe A; Ishibashi M; Watanabe T; Horie Y
    Brain Tumor Pathol; 2014 Jul; 31(3):187-91. PubMed ID: 24446079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.
    Shimon I; Hinton DR; Weiss MH; Melmed S
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):23-9. PubMed ID: 9509064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
    Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E
    Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H; Saeger W
    Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple pituitary adenoma in Cushing's disease: case report.
    Pantelia E; Kontogeorgos G; Piaditis G; Rologis D
    Acta Neurochir (Wien); 1998; 140(2):190-3. PubMed ID: 10399001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic pituitary adenoma located at the pituitary stalk. Case report.
    Peker S; Sun I; Kurtkaya-Yapicier O; Elmaci I; Pamir MN
    J Neurosurg Sci; 2005 Mar; 49(1):25-9. PubMed ID: 15990716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels.
    Smith MV; Laws ER
    Neurosurgery; 1994 May; 34(5):834-9; discussion 839. PubMed ID: 8052379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
    Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
    Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic prolactin cell hyperplasia of the pituitary mimicking prolactin cell adenoma: a morphological study including immunocytochemistry, electron microscopy, and in situ hybridization.
    Jay V; Kovacs K; Horvath E; Lloyd RV; Smyth HS
    Acta Neuropathol; 1991; 82(2):147-51. PubMed ID: 1927271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and post-operative hypothalamic-pituitary-thyroidal axis function in patients with prolactinoma, growth hormone tumour and ACTH tumour.
    Lu C; Lin XT; Yang DT; Liu YC; He WT; Zhong XL
    Chin Med J (Engl); 1989 Apr; 102(4):306-12. PubMed ID: 2551602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Silent adenoma type 3: the importance of the ultrastructural study in the differential diagnosis of pituitary adenoma associated with hyperprolactinemia in a case].
    Quevedo I; Rodríguez JA; Gejman R; Méndez J
    Rev Med Chil; 2001 Mar; 129(3):295-8. PubMed ID: 11372297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.